|Videos|July 14, 2020

Getting Younger People on PrEP

Why it's critical for the future of HIV prevention for programs like the California PrEP-AP to reach younger at-risk persons now.

Present-day HIV prevention is in an excellent spot. As discussed thoroughly in the International AIDS Society (IAS) AIDS 2020 Virtual Sessions, pre-exposure prophylaxis (PrEP) options are greatening and individualizing to the patient.

And programs including the California PrEP Assistance Program (PrEP-AP) have better bridged at-risk persons to information and means by which they can appropriately prevent HIV spread—while setting a model for other regional programs.

But what about the future of HIV prevention?

In an interview with Contagion during AIDS 2020, Philip Peters, MD, medical officer of the California Department of Public Health, discussed how programs like PrEP-AP are adapting to a new generation of HIV-risk persons—namely, by lowering its age limit to 12 years, in alignment with US Food and Drug Administration (FDA) approved marketing for PrEP.

Alongside this, they’ve made assurances that confidentiality and billing structure allows for minors and young adults on their parent’s/guardian’s health insurance would still receive the same care.

“If we can really keep looking at it from a systems standpoint—what are all the reasons people have trouble enrolling in the program—taking advantage of this benefit is hopefully going to help,” Philips said.


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures
Staphylococcus aureus Bacteremia (SAB) causes significant morbidity and globally is the leading cause of death from bloodstream infection. This month, the IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. Here is a closer look at Consensus Statement 2: Follow-up Blood Cultures.